People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...

Researchers delivered a dose of the “love hormone” oxytocin via a nasal spray to participants and found that it decreased ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...

Think of a building shading system that intelligently adapts to changing weather conditions, and operates without an external power. This is the vision behind the Solar Gate, a new shading system ...

Credit: PattyPhoto/Shutterstock. Vistagen has reported positive outcomes from the exploratory Phase IIA trial of an investigational pherine nasal spray, PH284, for the treatment of cancer cachexia.

Now, a growing group of scientists and companies say they’ve found a way to increase that storage capacity by tweaking ocean water chemistry. The technique, known as ocean alkalinity enhancement ...

After the AI boom, Nvidia has dominated the GPU and AI accelerator market. Valued at over $3 trillion, the company is now channeling its resources towards robotics, a transition Deepu Talla, VP of ...